The invention provides a variety of reagents for use in the diagnosis and management of breast cancer. The invention utilizes cDNA microarray technology to identify genes whose expression profile across a large group of tumor samples correlates with that of cytokeratin 5 and cytokeratin 17, markers for...http://www.google.fr/patents/US20030086934?utm_source=gb-gplus-shareBrevet US20030086934 - Basal cell markers in breast cancer and uses thereof
Basal cell markers in breast cancer and uses thereof
Numéro de demande: 09/916,849 Numéro de publication: US 2003/0086934 A1 Date de dépôt: 26 juil. 2001 Brevet délivré: US7118853 ( Date de délivrance 10 oct. 2006)
